NAFLD
March 13, 2020
As the coronavirus pandemic prompts cancellations of scientific meetings around the world and shifts to virtual settings, we have been working on alternative methods to keep you informed of advances […]
August 20, 2018
Pharma companies racing to accelerate drug discovery for chronic liver diseases, such as NASH and fibrosis, need better preclinical testing tools for compound screening and mechanistic studies. Here's how next-generation […]
June 18, 2018
In honor of the inaugural International NASH Day, Insphero explains why we need better preclinical models for non-alcoholic steatohepatitis (NASH) disease drug discovery. Non-alcoholic fatty liver disease (NAFLD) is one of […]